Adventa BhdXKLS:7191 36 Net Margin % is -19.37% as of Mar. 2026. GuruFocus rates XKLS:7191 with a GF Score™ of 36/100 and a GF Value™ of RM0.24 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Adventa Bhd ranks worse than 66.59% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Adventa Bhd's Net Income for the
three
months ended in Mar. 2026 was RM-1.97 Mil. Adventa Bhd's Revenue for the
three
months ended in Mar. 2026 was RM10.18 Mil. Therefore, Adventa Bhd's net margin for the quarter that ended in Mar. 2026 was -19.37%.
The historical rank and industry rank for Adventa Bhd's Net Margin % or its related term are showing as below:
XKLS:7191'
s Net Margin % Range Over the Past 10 Years
Min: -24.33 Med: 1.02 Max: 74.23
Current: -15.56
XKLS:7191's Net Margin % is ranked worse than 66.59% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.09
vs XKLS:7191: -15.56
Adventa Bhd (XKLS:7191) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Adventa Bhd Net Margin % Related Terms
Adventa Bhd Net Margin % Historical Data
* Premium members only.
The historical data trend for Adventa Bhd's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7191 vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Adventa Bhd's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adventa Bhd Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adventa Bhd's Net Margin % distribution charts can be found below:
* The bar in red indicates where Adventa Bhd's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adventa Bhd (XKLS:7191) has a Net Margin % of -19.37% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Adventa Bhd and its competitors. According to the industry distribution chart, Adventa Bhd ranks #544 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 66.6%.
Is Adventa Bhd's Net Margin % too high?
Adventa Bhd's current Net Margin % is -19.37%. Based on the distribution chart, Adventa Bhd ranks #544 out of 817 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Adventa Bhd has a GF Score™ of 36/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adventa Bhd's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Adventa Bhd ranks #544 out of 817 companies for Net Margin %. This places Adventa Bhd in the lower half of its industry. The industry median Net Margin % is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.09, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Adventa Bhd and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adventa Bhd's current Net Margin % is -19.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adventa Bhd stock overvalued right now?
Based on GuruFocus' analysis, Adventa Bhd (XKLS:7191) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.24, compared to a current price of RM0.13 — trading 45.8% below its estimated fair value. The current Net Margin % is -19.37%. Adventa Bhd's overall GF Score™ is 36/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Adventa Bhd (XKLS:7191), the current Net Margin % is -19.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adventa Bhd (XKLS:7191) Overvalued in 2026?
Based on GuruFocus' analysis, Adventa Bhd stock appears to be undervalued.
The current stock price of RM0.13 is trading 45.8% below its estimated GF Value™ of RM0.24.
GuruFocus considers Adventa Bhd to be Possible Value Trap.
Key valuation signals for XKLS:7191:
Net Margin %: -19.37%
GF Value™: RM0.24 vs. price of RM0.13 (45.8% below fair value)
No single metric tells the full story. See the XKLS:7191 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adventa Bhd is engaged in investment holdings, management services, warehousing services, and the manufacturing, distribution, and supply of medical and healthcare equipment, appliances, and medical disposal products. It operates as a regional healthcare group focused on medical innovation, manufacturing excellence, and patient-centered solutions. Its segments include Investment Holdings, which involves investment in companies; Healthcare Products, which involves the manufacturing and supply of healthcare-related products and services to hospitals, healthcare centres, and pharmacies and generates maximum revenue; and Warehousing Provider, which provides storage and warehousing services. The company generates maximum revenue from Malaysia, followed by Indonesia and other countries.
36GF Score
Get the complete analysis for XKLS:7191
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7191 has been successfully added to your 
